Want to join the conversation?
Specialty biopharmaceutical company $MNK reported its 4Q15 gross profit of $482.1MM, up 32.7% over prior-year quarter, primarily due to the performance of Acthar and INOMAX products from Specialty Brands segment. Adjusted gross profit as a percentage of net sales was 72.4% compared to 66.5% in the same prior year period.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.